Drug targeting to tumors: Concepts and barriers vs. ever more nanocarriers
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Presentation
- By: LAMMERS, Twan (RWTH Aachen University Clinic, Nanomedicine and Theranostics, Aachen, Germany)
- Co-author(s): Twan Lammers: Nanomedicine and Theranostics, RWTH Aachen University Clinic, Aachen, Germany
Nanomedicines are 1-1000 nm-sized carrier materials designed to improve the biodistribution and target site accumulation of systemically administered (chemo-)therapeutic drugs. By delivering drug molecules more efficiently to pathological sites, and by preventing them from accumulating in healthy tissues, nanomedicines beneficially affect the.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.